Jessica Machado
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The efficacy and safety of short-acting, full agonist opioids for symptom management of opioid withdrawal.
Journal: Addictive behaviors reports
Published: February 17, 2026
24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review.
Journal: Addiction science & clinical practice
Published: May 29, 2025
Pain Management Strategies for Patients Receiving Extended-Release Buprenorphine for Opioid Use Disorder: A Scoping Review.
Journal: Substance use : research and treatment
Published: February 25, 2025
Direct Induction of Buprenorphine Extended-Release: A Case Report.
Journal: Journal of addiction medicine
Published: January 09, 2025
24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.
Journal: Journal of psychoactive drugs
Published: November 19, 2024
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative.
Journal: Journal of addiction medicine
Published: November 06, 2024
Case series: Symptom-inhibited fentanyl induction (SIFI) onto treatment-dose opioid agonist therapy in a community setting.
Journal: The American journal on addictions
Published: October 29, 2024
Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report.
Journal: Addiction science & clinical practice
Published: October 03, 2024
Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy.
Journal: Frontiers in psychiatry
Published: September 23, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026